You just read:

Genomic Health Marks More than 1 Million Patients Worldwide Who Have Benefited from Oncotype DX Testing in Personalizing Cancer Treatment Decisions to Improve Outcomes

News provided by

Genomic Health, Inc.

Jan 07, 2019, 08:00 ET